Robeco Institutional Asset Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-13,345
| Closed | -$368K | – | 887 |
|
|
2025
Q2 | $368K | Sell |
13,345
-17,408
| -57% | -$458K | ﹤0.01% | 818 |
|
|
2025
Q1 | $872K | Sell |
30,753
-1,243
| -4% | -$44.1K | ﹤0.01% | 803 |
|
|
2024
Q4 | $1.33M | Sell |
31,996
-12,015
| -27% | -$574K | ﹤0.01% | 755 |
|
|
2024
Q3 | $2.94M | Sell |
44,011
-46,337
| -51% | -$4.25M | 0.01% | 639 |
|
|
2024
Q2 | $10.7M | Buy |
90,348
+7,500
| +9% | +$949K | 0.02% | 412 |
|
|
2024
Q1 | $8.83M | Sell |
82,848
-11,676
| -12% | -$1.18M | 0.02% | 449 |
|
|
2023
Q4 | $9.4M | Sell |
94,524
-46,304
| -33% | -$3.89M | 0.02% | 454 |
|
|
2023
Q3 | $14.5M | Sell |
140,828
-118,995
| -46% | -$13.3M | 0.04% | 369 |
|
|
2023
Q2 | $31.6M | Sell |
259,823
-22,532
| -8% | -$3.01M | 0.08% | 246 |
|
|
2023
Q1 | $43.4M | Buy |
282,355
+6,674
| +2% | +$1.1M | 0.12% | 191 |
|
|
2022
Q4 | $49.5M | Buy |
275,681
+10,307
| +4% | +$1.69M | 0.14% | 166 |
|
|
2022
Q3 | $31.4M | Buy |
265,374
+9,936
| +4% | +$1.51M | 0.1% | 193 |
|
|
2022
Q2 | $36.5M | Buy |
255,438
+32,177
| +14% | +$4.6M | 0.11% | 180 |
|
|
2022
Q1 | $38.5M | Buy |
223,261
+22,022
| +11% | +$3.71M | 0.09% | 225 |
|
|
2021
Q4 | $51.1M | Sell |
201,239
-50,360
| -20% | -$14.7M | 0.11% | 208 |
|
|
2021
Q3 | $96.8M | Sell |
251,599
-25,126
| -9% | -$9.27M | 0.21% | 119 |
|
|
2021
Q2 | $65M | Buy |
276,725
+95,419
| +53% | +$17.1M | 0.14% | 160 |
|
|
2021
Q1 | $23.7M | Buy |
181,306
+22,615
| +14% | +$3.28M | 0.06% | 316 |
|
|
2020
Q4 | $16.6M | Buy |
158,691
+12,842
| +9% | +$1.3M | 0.04% | 366 |
|
|
2020
Q3 | $10.3M | Buy |
145,849
+22,880
| +19% | +$1.6M | 0.03% | 403 |
|
|
2020
Q2 | $7.9M | Buy |
122,969
+119,138
| +3,110% | +$6.52M | 0.03% | 454 |
|
|
2020
Q1 | $115K | Buy |
+3,831
| New | +$88.1K | ﹤0.01% | 926 |
|
Other funds holding MRNA
TP
